A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
Clinical trial NCT03538691 · COMPLETED
Trial details
- NCT number
- NCT03538691
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2022-07-08
- Enrollment
- 1149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.